Therefore, these data are presented descriptively in the Supplementary Material (Table S2)
MiR-27a inhibits the expression of several lipid metabolic genes, including SREBP1-2, FASN, and PPAR/, by reducing lipid synthesis and increasing lipid secretion from cells 92
Abhi Pathak, Chief Product Officer Number of Employees: ~397 Stage: Late-stage VC Financial Snapshot: Raised $168 million to date Notable Investors: Hedosophia, March Capital, Venrock, Flare Capital Partners, Zoom Ventures, Gaingels, Canal Pointe Capital Key products: AI assistant that handles documentation, coding, and clinical queries, with deep integration into major electronic health record systems Recent highlights: In January 2026, Suki announced a partnership with HealthEdge that brings ambient clinical intelligence directly into health plan care manager workflows
The drug companies were in a weird situation of having a drug that was too popular